---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-012130"
form_type: "8-K"
ticker: "NXTS"
cik: "0001789192"
company_name: "Nexentis Technologies Inc."
filed_at: "2025-08-18T23:59:59+00:00"
generated_at: "2026-05-17T11:59:30.216752+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# N2OFF (NITO) provides $372K bridge loan to MitoCareX Bio pending acquisition

## Summary
- Loan principal $372,000 from N2OFF to MitoCareX Bio Ltd., term 6 months, interest at Israel Tax Authority USD rate +3%.
- Disbursement in three tranches: $200K at signing, $86K on Sep 15, 2025, $86K on Oct 15, 2025.
- L.I.A. Pure Capital Ltd. guarantees full repayment of principal and interest.
- If acquisition closes, outstanding loan amount deducted from first-year allocation to MitoCareX.
- Loan supports MitoCareX's ongoing costs until acquisition stockholder approval and closing.

## SEC filing metadata
- accession: 0001493152-25-012130
- form_type: 8-K
- ticker: NXTS
- cik: 0001789192
- company_name: Nexentis Technologies Inc.
- filed_at: 2025-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789192/000149315225012130/0001493152-25-012130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789192/000149315225012130/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-012130
- JSON: https://secwatch.observer/filing/0001493152-25-012130.json
- Plain text: https://secwatch.observer/filing/0001493152-25-012130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.